Getein D-Dimer Fast Test Kit is used as an aid in the assessment and evaluation of patients suspected of deep-vein thrombosis or pulmonary embolism.
D-Dimer Fast Test Kit
(Immunofluorescence Assay)
Intended Use
D-Dimer Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of D-Dimer in human plasma or whole blood samples. The test is used as an aid in the assessment and evaluation of patients suspected of deep-vein thrombosis or pulmonary embolism.
About D-Dimer
D-Dimer is a marker of endogenous fibrinolysis and should therefore be detectable in patients with deep-vein thrombosis. In recent years, an increasing number of studies have shown the D-Dimer assay has a high negative predictive value and D-Dimer is a sensitive but nonspecific marker of deep-vein thrombosis. Negative D-Dimer can exclude deep-vein thrombosis and pulmonary embolism.
Contents
1. For Getein1100/ Getein1180
Package specifications: 25 tests/box, 10 tests/box
1) D-Dimer test card in a
sealed pouch with desiccant
2) Disposable pipet
3) Sample diluent
4) User manual: 1 piece/box
5) SD card: 1 piece/box
2. For Getein1600
Package specifications: 2×24 tests/kit, 2×48 tests/kit:
1) Sealed cartridge with 24/48
Getein D-Dimer test cards
2) User manual: 1 piece/box
Materials required for Getein1600:
1) Sample diluent: 1 bottle/box
2) Box with pipette tips: 96 tips/box
3) Mixing plate: 1 piece/box
Note: Do not mix or interchange different batches of kits.
Specifications
Test Item |
Sample |
Detection Range |
Storage Condition |
D-Dimer |
P/WB |
0.1-10.0 mg/L |
4-30℃ |
Method |
Test Time |
Cut-off Value |
Shelf Life |
Immunofluorescence Assay |
10 min |
0.5 mg/L |
24 months |
Applicable Device
Getein1100 Immunofluorescence Quantitative Analyzer
Getein1180 Immunofluorescence Quantitative Analyzer
Getein1600 Immunofluorescence Quantitative Analyzer
Clinical Application
1. As an aid in the exclusion of venous thromboembolism (VTE);
2. As an aid in the exclusion of pulmonary embolism (PE);
3. As an aid in the diagnosis of disseminated intravascular coagulation (DIC);
4. As an aid in the diagnosis and prognosis of cerebral infarction;
5. As an aid in the evaluation of coagulation status of pregnancy-induced hypertension;
6. As an aid in the diagnosis and prognosis of patients with surgery; monitor the thrombolytic therapy.